A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.

Phase 2TerminatedNCT00353808

Pfizer112 enrolled

Overview

The purpose of this study is to assess the long-term safety and tolerability of \[S,S\]-Reboxetine in patients with chronic pain following shingles. This is the extension study of Protocol A6061026.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

112

Conditions

Pain

Interventions

[S,S]-ReboxetineDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients must have met the patient selection criteria for the preceding double-blind Protocol A6061026 and have completed the 16-week trial. * Patients at screening must have a score of \>/=40mm on the pain visual analogue scale. Exclusion Criteria: * Serious adverse event during the preceding double-blind Protocol A6061026 that was determined to be related to the trial medication by the Investigator. * Patient treatment compliance was less than 80% in the preceding double-blind Protocol A6061026.

Locations (57)

Outcomes

Primary Outcomes

Vital signs

Physical examination

12-lead ECG

Hematology/Biochemistry

Adverse events

Secondary Outcomes

Pain Visual Analogue Scale

Patient Global Impression of Change

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Pfizer Investigational Site

Huntsville, Alabama, United States

Pfizer Investigational Site

Chandler, Arizona, United States

Pfizer Investigational Site

Gilbert, Arizona, United States

Pfizer Investigational Site

Sun City, Arizona, United States

Pfizer Investigational Site

Tucson, Arizona, United States

Pfizer Investigational Site

Arcadia, California, United States

Pfizer Investigational Site

Fullerton, California, United States

Pfizer Investigational Site

Irvine, California, United States

Pfizer Investigational Site

Laguna Hills, California, United States

Pfizer Investigational Site

Loma Linda, California, United States

...and 47 more locations